BiotechTubeBiotechTube
Home/Pipeline/ABBV-154

ABBV-154

Solid tumors

Phase 1Active

Key Facts

Indication
Solid tumors
Phase
Phase 1
Status
Active
Company
AbbVie

About AbbVie

AbbVie Inc. is a research-based biopharmaceutical company formed in 2013 as a spinoff from Abbott Laboratories. The company focuses on developing and delivering innovative therapies that address some of the world's most complex and serious diseases. With a strong portfolio led by immunology treatments and a growing oncology franchise, AbbVie has established itself as a leader in specialty therapeutics with global operations and a commitment to advancing patient care.

View full company profile

Therapeutic Areas

ImmunologyOncologyNeuroscienceEye CareVirology

Other Solid tumors Drugs

DrugCompanyPhase
GSK4362676GSK plcPhase 1
TAK-981Takeda PharmaceuticalPhase 1/2
TAK-676Takeda PharmaceuticalPhase 1
TAK-573Takeda PharmaceuticalPhase 1
TAK-164Takeda PharmaceuticalPhase 1
SHR-1316Jiangsu Hengrui MedicinePhase 1/2
BAY 2927088BayerPhase 1
ASP1929Astellas PharmaPhase 2
IBI188Innovent BiologicsPhase 1
Bispecific AntibodyAkesoPhase 1/2
CSPC-DM02CSPC Pharmaceutical Group LimitedPhase 2
ONO-4538 combinationsOno PharmaceuticalPhase 2